Numerous pathogens can infect the olfactory tract, yet the pandemic caused by SARS-CoV-
2 has strongly emphasized the importance of the olfactory mucosa as an immune barrier …

The gut has been proposed as a potential alternative entry route for SARS-CoV-2. This was
mainly based on the high levels of SARS-CoV-2 receptor expressed in the gastrointestinal …

Type I interferons (IFN-I) are critical mediators of innate control of viral infections but also
drive the recruitment of inflammatory cells to sites of infection, a key feature of severe …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the ongoing
global pandemic associated with morbidity and mortality in humans. Although disease …

Despite intensive research since the emergence of SARS-CoV-2, it has remained unclear
precisely which components of the early immune response protect against the development …

Pediatric SARS-CoV-2 vaccines are needed that elicit immunity directly in the airways as
well as systemically. Building on pediatric parainfluenza virus vaccines in clinical …

Viral co-infections have been implicated in worsening tuberculosis (TB) and during the
COVID-19 pandemic, the global rate of TB-related deaths has increased for the first time in …

Identifying host genes essential for Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has the potential to reveal novel drug targets and further our understanding …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
diverse clinical manifestations and tissue injuries in multiple organs. However, cellular and …

Introduction The SARS-CoV-2 infection has been advocated as an environmental trigger for
autoimmune diseases, and a paradigmatic example comes from similarities between COVID …